pharmaphorum

JANUARY 30, 2023

Moreover, more than any other medicine, antibiotics are more likely to face insufficient supply, with analysis by the US Pharmacopeia suggesting they are 42% more likely to be in shortage compared to all other drugs. Larger questions remain around the way in which to support manufacturers to invest in production capabilities for antibiotics.

Generic Medicine 104

Generic Medicine Packaging FDA Labelling 104

Pharmaceutical Technology

MAY 3, 2023

Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. These medicines comprise about 10% of all generics approved each year. Still, the FDA does prioritize the review of submissions for first generics.

FDA 98

FDA Generic Medicine Communication 98

pharmaphorum

JANUARY 4, 2023

It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US. Hospira isn’t the only generics company trying to bring a version of regadenoson to the US market.

Generic Medicine 59

Generic Medicine FDA 59

pharmaphorum

SEPTEMBER 26, 2022

Astellas has won a reprieve in its attempt to stop Pfizer’s generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks. ” Hospira isn’t the only generics company trying to bring a version of regadenoson to the US market.

Generic Medicine 52

Generic Medicine FDA 52

The Checkup by Singlecare

OCTOBER 12, 2023

Abilify first received FDA approval in 2002. Although Abilify is well known by its brand name, an Abilify generic is available. The generic name of Abilify is aripiprazole, commonly prescribed for mental health conditions. Aripiprazole was approved by the FDA in 2015. mL, 960 mg/3.2

Dosage 52

Dosage Labelling FDA Adverse Reactions 52